Celyad Oncology S.A.
CYAD.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€5,824 | -€8,448 | -€40,935 | -€26,512 |
| Dep. & Amort. | €450 | €794 | €1,440 | €1,520 |
| Deferred Tax | €0 | €0 | €0 | -€531 |
| Stock-Based Comp. | €0 | €935 | €1,624 | €2,172 |
| Change in WC | -€177 | -€1,205 | -€4,015 | €1,405 |
| Other Non-Cash | -€129 | -€7,278 | €13,876 | -€4,697 |
| Operating Cash Flow | -€5,680 | -€15,202 | -€28,010 | -€26,643 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€118 | -€934 | -€123 | -€393 |
| Net Acquisitions | €15 | €0 | €6,000 | €0 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €0 | €0 | €1,090 | €0 |
| Other Inv. Act. | €0 | €1,341 | €235 | €267 |
| Investing Cash Flow | -€103 | €407 | €7,202 | -€126 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€167 | -€145 | -€896 | -€1,136 |
| Stock Issued | €0 | €9,490 | €0 | €36,568 |
| Stock Repurch. | €0 | €0 | -€124 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €3,150 | €10 | €4,261 | €4,089 |
| Financing Cash Flow | €2,983 | €9,355 | €3,241 | €39,521 |
| Forex Effect | -€4 | -€1 | -€6 | €32 |
| Net Chg. in Cash | -€2,804 | -€5,441 | -€17,573 | €12,784 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €7,004 | €12,445 | €30,018 | €17,234 |
| End Cash | €4,200 | €7,004 | €12,445 | €30,018 |
| Free Cash Flow | -€5,680 | -€16,101 | -€28,133 | -€27,036 |